Maxcyte (MXCT) Shares Outstanding (2020 - 2026)
Maxcyte (MXCT) Shares Outstanding (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 385.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 456.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 867.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 951.57 Mn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | 106.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.88 Mn |
| Dec 31, 2025 | 106.43 Mn |
| Sep 30, 2025 | 106.61 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | 105.95 Mn |
| Dec 31, 2024 | 104.85 Mn |
| Sep 30, 2024 | 105.11 Mn |
| Jun 30, 2024 | 104.64 Mn |
| Mar 31, 2024 | 104.09 Mn |
| Dec 31, 2023 | 103.27 Mn |
| Sep 30, 2023 | 103.45 Mn |
| Jun 30, 2023 | 103.06 Mn |
| Mar 31, 2023 | 102.85 Mn |
| Dec 31, 2022 | 101.70 Mn |
| Sep 30, 2022 | 101.81 Mn |
| Jun 30, 2022 | 101.43 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 90.62 Mn |
| Sep 30, 2021 | 84.71 Mn |
| Jun 30, 2021 | 84.71 Mn |